Given the dramatic efficacy of warfarin, why is it not given to everyone with AF? Unfortunately, warfarin is a narrow therapeutic index drug affected by numerous factors. For AF, the optimal ...

Patients with atrial fibrillation receiving routine medical care within a large managed care organization were found to have suboptimal anticoagulation control. Retrospective cross-sectional study of ...

When using current guideline recommendations, the clinical net benefit of starting oral anticoagulation varied widely among patients with atrial fibrillation, according to findings published in Annals ...

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia that significantly elevates the risk of thromboembolic events, most notably ischaemic stroke. Anticoagulation therapy has long been a ...

Vitamin K-inhibiting anticoagulants, especially warfarin, have become standard treatment for reducing the incidence of strokes and systemic emboli in patients with nonvalvular atrial fibrillation ...

It’s time to do an update on the treatment of atrial fibrillation. It’s been a while, and there are worthy things to report from the real world. Always start with basics: The most important aspect of ...

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation.

Blood thinners (anticoagulants) cause bleeding without preventing stroke in patients with atrial high rate episodes (AHRE), but without electrocardiogram (ECG)-diagnosed atrial fibrillation, according ...

The net clinical benefit of anticoagulants for atrial fibrillation (AF) -- one of the most important causes of irregular heartbeats and a leading cause of stroke -- decreases with age, as the risk of ...

A recent wave of oral anticoagulants is paving the way toward better stroke prevention in patients with atrial fibrillation (A-fib), according to a meta-analysis published online April 27, 2012, ahead ...

Objective: To evaluate data addressing use of anticoagulation in elderly patients with atrial fibrillation (AF), in particular those at risk of falls. Data Sources: Primary literature was identified ...

MUNICH, Germany—Among patients undergoing TAVR for the treatment of aortic stenosis, male sex, moderate-to-severe renal failure, and atrial fibrillation are independent predictors of death at 3 years, ...